Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis

被引:170
作者
Edamoto, Y
Hara, A
Biernat, W
Terracciano, L
Cathomas, G
Riehle, HM
Matsuda, M
Fujii, H
Scoazec, JY
Ohgaki, H
机构
[1] Int Agcy Res Canc, Unit Mol Pathol, F-69372 Lyon 08, France
[2] Univ Basel, Dept Pathol, Basel, Switzerland
[3] Kantonales Inst Pathol, Liestal, Switzerland
[4] Univ Zurich Hosp, Inst Clin Pathol, Dept Pathol, CH-8091 Zurich, Switzerland
[5] Univ Yamanashi, Sch Med, Dept Surg 1, Yamanashi, Japan
[6] Hop Edouard Herriot, Lab Pathol Anat, Lyon, France
关键词
hepatocellular carcinoma; p53; RB1; cyclin D1; beta-catenin; HCV; HBV; alcohol;
D O I
10.1002/ijc.11254
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Major etiologic factors associated with human hepatocellular carcinomas (HCCs) include infection with hepatitis C (HCV) and hepatitis B virus (HBV), excess alcohol intake and aflatoxin B-1 exposure. While the G-->T p53 mutation at codon 249 has been identified as a genetic hallmark of HCC caused by aflatoxin B-1 the genetic profile associated with other etiologic factors appears to be less distinctive. In our study, we screened HCCs resulting from HCV infection (5 1 cases), HBV infection (26 cases) or excess alcohol intake (23 cases) for alterations in genes involved in the RB I pathway (p16(INK4a), p15(INK4b) RBI CDK4 and cyclin DI), the p53 pathway (p53, p14(ARF) and MDM2) and the Writ pathway (beta-catenin, APC). Alterations of the RBI pathway, mainly p16(INK4a) methylation, loss of 11131 expression and cyclin D1 amplification, were most common (69-100% of cases). There was a significant correlation between loss of RB I expression and RB I methylation. All 24 HCCs with RB I promoter methylation lacked RBI expression, while none of the 67 cases with RBI expression exhibited RBI methylation(p < 0.0001), suggesting that promoter methylation is a major mechanism of loss of RBI expression in HCCs. Alterations of the p53 pathway consisted mostly of p53 mutations or p14ARF promoter methylation (20-48%). Mutations of the p53 gene were found at a similar frequency (13-15%) in all etiologic groups, without any consistent base change or hot spot. Mutations of beta-catenin were found in 13-31% of cases, while no APC mutations were detected in any of the HCCs analyzed. With the exception of only 3 of 39 cases (8%), cyclin D I amplification and beta-catenin mutations were mutually exclusive, supporting the view that cyclin D I is a target of the Wnt signaling pathway. Overall, the RB I, p53 and Writ pathways were commonly affected in HCCs of different etiology, probably reflecting common pathogenetic mechanisms, i.e., chronic liver injury and cirrhosis, but tumors associated with alcoholism had more frequent alterations in the RB I and p53 pathways than those caused by HCV infection. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 55 条
[1]   In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions [J].
Abe, K ;
Edamoto, Y ;
Park, YN ;
Nomura, AMY ;
Taltavull, TC ;
Tani, M ;
Thung, SN .
HEPATOLOGY, 1998, 28 (02) :568-572
[2]  
Ashida K, 1997, J CANCER RES CLIN, V123, P489
[3]  
Baek MJ, 2000, CANCER, V89, P60, DOI 10.1002/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO
[4]  
2-3
[5]   TCF: Lady justice casting the final verdict on the outcome of Wnt signalling [J].
Brantjes, H ;
Barker, N ;
van Es, J ;
Clevers, H .
BIOLOGICAL CHEMISTRY, 2002, 383 (02) :255-261
[6]   Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) [J].
Bréchot, C ;
Gozuacik, D ;
Murakami, Y ;
Paterlini-Bréchot, P .
SEMINARS IN CANCER BIOLOGY, 2000, 10 (03) :211-231
[7]  
BRUSTLE O, 1992, CANCER, V69, P2385, DOI 10.1002/1097-0142(19920501)69:9<2385::AID-CNCR2820690929>3.0.CO
[8]  
2-3
[9]  
Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185
[10]  
Chiesa R, 2000, CANCER EPIDEM BIOMAR, V9, P213